Prime Medicine, Inc Common Stock

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,225
$1,115
$1,454
$2,183
Gross Profit
-42,765
-749
1,454
2,183
EBITDA
-48,701
-51,513
-50,692
-42,505
EBIT
-50,582
-53,377
-52,392
-44,222
Net Income
-50,582
-52,591
-51,890
-42,276
Net Change In Cash
1,225
1,115
1,454
2,183
Free Cash Flow
-35,286
-42,984
-51,279
14,454
Cash
71,396
53,804
91,877
182,476
Basic Shares
160,503
129,185
130,884
118,600

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$2,983
$0
$5,210
$0
Gross Profit
2,983
-4,653
-12,014
-4,861
EBITDA
-196,339
-186,639
-114,320
-83,906
EBIT
-202,467
-191,292
-116,544
-84,474
Net Income
-195,882
-198,133
-121,821
-165,367
Net Change In Cash
2,983
0
5,210
0
Cost of Revenue
2,571
Free Cash Flow
-130,159
-174,136
-147,922
-38,232
Cash
182,476
41,574
187,620
185,420
Basic Shares
118,600
90,969
97,209
95,730

Earnings Calls

QuarterEPS
2025-09-30
-$0.32
2025-06-30
-$0.41
2025-03-31
-$0.40
2024-12-31
-$0.31